Skip to main content

Table 1 Demographic and clinical characteristics from participants included in the analysis (n = 93)

From: Categorisation of foot complaints in systemic lupus erythematosus (SLE) from a New Zealand cohort

Characteristic

Value

Female sex, n (%)

87 (93.7)

Age (years), mean (SD)

50.4 (14.3)

Disease duration (years), mean (SD)

13.1 (11)

BMI (kg/m2), mean (SD)

28.2 (6.6)

Current smoker, n (%)

20 (21)

Employment status, n (%)

 Paid work

51 (53)

 Not working

21 (23)

 Retired

14 (16)

 Unpaid work

5 (6)

 Sick leave

1 (1)

 Full-time education

1 (1)

Ethnicity, n (%)

 New Zealand European

47 (51)

 Pacific Island

17 (19)

 Asian

13 (14)

 Māori

8 (9)

 Chinese

5 (6)

 Afro-carribean

1 (1)

Medication use a

 Hydroxychloroquine, n (%)

75 (81)

 Azathioprine, n (%)

18 (19)

 Methotrexate, n (%)

16 (17)

 Mycophenolate, n (%)

4 (4)

 Cyclophosphamide, n (%)

2 (2)

Oral glucocorticoid use, n (%)

43 (46)

Non-steroidal anti-inflammatory drug use, n(%)

26 (28)

Rituximab use, n (%)

5 (6)

  1. aFigures may not add to 100% where some participants took more than one medication